These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 35646728

  • 1. QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country.
    Pongsakornkullachart K, Chayakulkeeree M, Vongwiwatana A, Kantakamalakul W, Skulratanasak P, Phoompoung P.
    Front Cell Infect Microbiol; 2022; 12():893232. PubMed ID: 35646728
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
    Deborska-Materkowska D, Perkowska-Ptasinska A, Sadowska A, Gozdowska J, Ciszek M, Serwanska-Swietek M, Domagala P, Miszewska-Szyszkowska D, Sitarek E, Jozwik A, Kwiatkowski A, Durlik M.
    BMC Infect Dis; 2018 Apr 16; 18(1):179. PubMed ID: 29661141
    [Abstract] [Full Text] [Related]

  • 3. QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.
    Reusing JO, Agena F, Kotton CN, Campana G, Pierrotti LC, David-Neto E.
    Transplantation; 2024 Apr 01; 108(4):985-995. PubMed ID: 37990351
    [Abstract] [Full Text] [Related]

  • 4. Torque teno virus viremia and QuantiFERON®-CMV assay in prediction of cytomegalovirus reactivation in R+ kidney transplant recipients.
    Mafi S, Essig M, Rerolle JP, Lagathu G, Crochette R, Brodard V, Schvartz B, Gouarin S, Bouvier N, Engelmann I, Garstka A, Bressollette-Bodin C, Cantarovitch D, Germi R, Janbon B, Archimbaut C, Heng AE, Garnier F, Gomes-Mayeras M, Labrunie A, Hantz S, Alain S.
    Front Med (Lausanne); 2023 Apr 01; 10():1180769. PubMed ID: 37425298
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
    Abate D, Saldan A, Fiscon M, Cofano S, Paciolla A, Furian L, Ekser B, Biasolo MA, Cusinato R, Mengoli C, Bonfante L, Rossi B, Rigotti P, Sgarabotto D, Barzon L, Palù G.
    J Infect Dis; 2010 Aug 15; 202(4):585-94. PubMed ID: 20594105
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
    Lee H, Park KH, Ryu JH, Choi AR, Yu JH, Lim J, Han K, Kim SI, Yang CW, Chung BH, Oh EJ.
    PLoS One; 2017 Aug 15; 12(12):e0189488. PubMed ID: 29232714
    [Abstract] [Full Text] [Related]

  • 7. Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients.
    Paouri B, Soldatou A, Petrakou E, Theodosaki M, Tsentidis C, Kaisari K, Oikonomopoulou C, Matsas M, Goussetis E.
    Pediatr Transplant; 2018 Aug 15; 22(5):e13220. PubMed ID: 29777573
    [Abstract] [Full Text] [Related]

  • 8. Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
    Tarasewicz A, Dębska-Ślizień A, Rutkowski B.
    Transplant Proc; 2016 Jun 15; 48(5):1650-3. PubMed ID: 27496465
    [Abstract] [Full Text] [Related]

  • 9. Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ response.
    Páez-Vega A, Poyato A, Rodriguez-Benot A, Guirado L, Fortún J, Len O, Abdala E, Fariñas MC, Cordero E, de Gracia C, Hernández D, González R, Torre-Cisneros J, Cantisán S, Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016), Spanish Renal Disease Network (REDinREN, RD16/0009).
    Antiviral Res; 2018 Jul 15; 155():97-105. PubMed ID: 29782877
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
    Gabanti E, Lilleri D, Scaramuzzi L, Zelini P, Rampino T, Gerna G.
    New Microbiol; 2018 Jul 15; 41(3):195-202. PubMed ID: 30028473
    [Abstract] [Full Text] [Related]

  • 11. Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.
    Singh N, Winston DJ, Razonable RR, Lyon GM, Silveira FP, Wagener MM, Stevens-Ayers T, Edmison B, Boeckh M, Limaye AP.
    JAMA; 2020 Apr 14; 323(14):1378-1387. PubMed ID: 32286644
    [Abstract] [Full Text] [Related]

  • 12. Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R-): A Case Series.
    Andreani M, Albano L, Benzaken S, Cassuto E, Jeribi A, Caramella A, Giordanengo V, Bernard G, Esnault V, Seitz-Polski B.
    Transplant Proc; 2020 Apr 14; 52(1):204-211. PubMed ID: 31889538
    [Abstract] [Full Text] [Related]

  • 13. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
    Chiereghin A, Potena L, Borgese L, Gibertoni D, Squarzoni D, Turello G, Petrisli E, Piccirilli G, Gabrielli L, Grigioni F, Lazzarotto T.
    J Clin Microbiol; 2018 Apr 14; 56(4):. PubMed ID: 29305542
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation.
    De Gracia-Guindo MDC, Ruiz-Fuentes MDC, Galindo-Sacristán P, Osorio-Moratalla JM, Ruiz-Fuentes N, Rodriguez Granger J, Osuna-Ortega A.
    Transplant Proc; 2018 Mar 14; 50(2):578-580. PubMed ID: 29579857
    [Abstract] [Full Text] [Related]

  • 15. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M.
    Mikrobiyol Bul; 2016 Apr 14; 50(2):224-35. PubMed ID: 27175495
    [Abstract] [Full Text] [Related]

  • 16. Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients.
    Abate D, Saldan A, Mengoli C, Fiscon M, Silvestre C, Fallico L, Peracchi M, Furian L, Cusinato R, Bonfante L, Rossi B, Marchini F, Sgarabotto D, Rigotti P, Palù G.
    J Clin Microbiol; 2013 Aug 14; 51(8):2501-7. PubMed ID: 23678073
    [Abstract] [Full Text] [Related]

  • 17. Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation.
    Páez-Vega A, Cantisán S, Agüera ML, Suñer M, Facundo C, Yuste JR, Fernández-Ruiz M, Montejo M, Redondo-Pachón D, López-Oliva MO, Fernández-Rodríguez A, Fariñas MC, Hernández D, Len O, Muñoz P, Valle-Arroyo J, Rodelo-Haad C, Cordero E, Torre-Cisneros J.
    J Infect Dis; 2021 Apr 08; 223(7):1205-1213. PubMed ID: 32779713
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers.
    Rao M, Finny GJ, Abraham P, Juneja R, Thomas PP, Jacob CK, Sridharan G.
    Nephron; 2000 Apr 08; 84(4):367-73. PubMed ID: 10754415
    [Abstract] [Full Text] [Related]

  • 19. Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients.
    Kruger RM, Paranjothi S, Storch GA, Lynch JP, Trulock EP.
    J Heart Lung Transplant; 2003 Jul 08; 22(7):754-63. PubMed ID: 12873543
    [Abstract] [Full Text] [Related]

  • 20. QuantiFERON-CMV and monitor predict cytomegalovirus, mortality, and graft-versus-host disease in transplant recipients.
    Souan L, Jazar HA, Nashwan S, Sughayer MA.
    J Med Virol; 2023 Nov 08; 95(11):e29250. PubMed ID: 38009250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.